Major factors affecting the emergence and re-emergence of infectious diseases

Clinics in Laboratory Medicine

Volumn 24, Issue 3, 2004, Pages 559-586

  Church, Deirdre L ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b CALGARY LABORATORY SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AIRPORT; ALZHEIMER DISEASE; BEHAVIOR; BIOLOGICAL WARFARE; CAMPYLOBACTER; CHILD CARE; CHLAMYDIA TRACHOMATIS; CHRONIC DISEASE; CHRONIC LIVER DISEASE; CLINICAL FEATURE; COST BENEFIT ANALYSIS; DAY CARE; DEMOGRAPHY; DEVELOPING COUNTRY; DIPHTHERIA; EPIDEMIC; FLUID INTAKE; FOOD CONTAMINATION; FOOD INTAKE; GASTROINTESTINAL INFECTION; GIARDIASIS; GLOBAL CHANGE; GLOBAL CLIMATE; GREENHOUSE EFFECT; HANTAVIRUS PULMONARY SYNDROME; HEALTH BEHAVIOR; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDUSTRIALIZATION; INFECTION; INTESTINE INFECTION; LAND USE; LIFESTYLE; LIVER CARCINOMA; LIVER CIRRHOSIS; MICROORGANISM DETECTION; MORBIDITY; MORTALITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIPLE SCLEROSIS; NEISSERIA GONORRHOEAE; NONHUMAN; POLYMERASE CHAIN REACTION; POPULATION DISTRIBUTION; POPULATION GROWTH; POPULATION MOVEMENT PATTERN; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; ROTAVIRUS; SALMONELLA; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SHIGELLA; SJOEGREN SYNDROME; STREPTOCOCCUS PNEUMONIAE; SYPHILIS; TROPICS; URBAN AREA; VIBRIO CHOLERAE; WATER SUPPLY;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; COMMUNICABLE DISEASES, EMERGING; HUMANS; WORLD HEALTH;

EID: 8444247412     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2004.05.008     Document Type: Review

References (164)

1. World Health Organization. The World Health Report 1996: fighting disease, fostering development. 1996;World Health Organization, Geneva (Switzerland)
2. World Health Organization. The World Health Report 2000 - health systems: improving performance. 2000;World Health Organization, Geneva (Switzerland)
3. Pinner R.W., Teutsch S.M., Simonsen L., Klug L.A., Graber J.M., Clarke M.J., et al. Trends in infectious diseases mortality in the United States. JAMA. 275:(3):1996;189-193
4. Armstrong G.L., Conn L.A., Pinner R.W. Trends in infectious disease mortality in the United States during the 20th century. JAMA. 281:(1):1999;61-66
5. Centers for Disease Control. Addressing emerging infectious diseases threats: a prevention strategy for the United States. 1994;United States Centers for Disease Control, Atlanta (GA)
6. Institute of Medicine. Emerging infections: microbial threats to health in the United States. 1992;National Academy Press, Washington, DC
7. Rose J.B., Slifko T.R. Giardia, Cryptosporidium, and Cyclospora and their impact on foods: a review. J Food Prot. 62:(9):1999;1059-1070
8. Stevens D.L. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis. 1:(3):1995;69-78
9. Walker D.H., Barbour A.G., Oliver J.H., Lane R.S., Dumler J.S., Dennis D.T., et al. Emerging bacterial zoonotic and vector-borne diseases. Ecological and epidemiological factors. JAMA. 275:(6):1996;463-469
10. Meyer R.D., Edelstein P.H., Kirby B.D., Louie M.H., Mulligan M.E., Morgenstein A.A., et al. Legionnaires' disease: unusual clinical and laboratory features. Ann Intern Med. 93:(2):1980;240-243
11. Edelstein P.H., Meyer R.D. Legionnaires' disease. A review. Chest. 85:(1):1984;114-120
12. Blaser M.J. Helicobacter pylori and gastric diseases. BMJ. 316:(7143):1998;1507-1510
13. Pai C.H., Gordon R., Sims H.V., Bryan L.E. Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features. Ann Intern Med. 101:(6):1984;738-742
14. Rowe P.C., Orrbine E., Lior H., Wells G.A., McLaine P.N. A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators. Epidemiol Infect. 110:(1):1993;1-7
15. Walsh T.J., Groll A.H. Emerging fungal pathogens: evolving challenges to immunocompromised patients for the twenty-first century. Transpl Infect Dis. 1:(4):1999;247-261
16. Reed K.D., Mitchell P.D., Persing D.H., Kolbert C.P., Cameron V. Transmission of human granulocytic ehrlichiosis. JAMA. 273:(1):1995;23
17. Francesconi P., Yoti Z., Declich S., Onek P.A., Fabiani M., Olango J., et al. Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis. 9:(11):2003;1430-1437
18. Bausch D.G., Borchert M., Grein T., Roth C., Swanepoel R., Libande M.L., et al. Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo. Emerg Infect Dis. 9:(12):2003;1531-1537
19. Jelinek T. Dengue fever in international travelers. Clin Infect Dis. 31:(1):2000;144-147
20. Hales S., de Wet N., Maindonald J., Woodward A. Potential effect of population and climate changes on global distribution of dengue fever: an empirical model. Lancet. 360:2002;830-834
21. Hughes J.M., Peters C.J., Cohen M.L., Mahy B.W. Hantavirus pulmonary syndrome: an emerging infectious disease. Science. 262:(5135):1993;850-851
22. Engelthaler D.M., Mosley D.G., Cheek J.E., Levy C.E., Komatsu K.K., Ettestad P., et al. Climatic and environmental patterns associated with hantavirus pulmonary syndrome, Four Corners region, United States. Emerg Infect Dis. 5:(1):1999;87-94
23. Rappole J.H., Derrickson S.R., Hubalek Z. Migratory birds and spread of West Nile virus in the Western Hemisphere. Emerg Infect Dis. 6:(4):2000;319-328
24. Wu J. Risk factors for SARS among persons without known contact with SARS patients, Beijing, China. Emerg Infect Dis. 10:(2):2004;210-216
25. Lau J.T. SARS transmission among hospital workers in Hong Kong. Emerg Infect Dis. 10:(2):2004;280-286
26. Silverberg L.I., Demuth F. Western Nile Virus: a new public health concern. W V Med J. 97:(3):2001;157-159
27. O'Leary D.R., Marfin A.A., Montgomery S.P., Kipp A.M., Lehman J.A., Biggerstaff B.J., et al. The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis. 4:(1):2004;61-70
28. HIV epidemic - a global update. Excerpts from the UN World AIDS Day report. Health Millions. 24:(1):1998;3-5
29. De Cock K.M. The emergence of HIV/AIDS in Africa. Rev Epidemiol Sante Publique. 44:(6):1996;511-518
30. Shetty A.K., Powell G. Children orphaned by AIDS: a global perspective. Semin Pediatr Infect Dis. 14:(1):2003;25-31
31. Mertens T. HIV/AIDS: trends of the pandemic. Glob AIDSnews. 3-4:1995;8-9
32. Selik R.M., Karon J.M., Ward J.W. Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993. J Infect Dis. 176:(3):1997;632-636
33. Asia: fastest growing AIDS problem. Reprowatch. 17:(4):1998;1-2
34. Aliyu M.H., Salihu H.M. Tuberculosis and HIV disease: two decades of a dual epidemic. Wien Klin Wochenschr. 115:(19-20):2003;685-697
35. Rowland-Jones S.L., Lohman B. Interactions between malaria and HIV infection - an emerging public health problem? Microbes Infect. 4:(12):2002;1265-1270
36. James S.L. Emerging parasitic infections. FEMS Immunol Med Microbiol. 18:(4):1997;313-317
37. Song A.T., Schout D., Novaes H.M., Goldbaum M. Clinical and epidemiological features of AIDS/tuberculosis comorbidity. Rev Hosp Clin Fac Med São Paulo. 58:(4):2003;207-214
38. Witt V.M., Reiff F.M. Environmental health conditions and cholera vulnerability in Latin America and the Caribbean. J Public Health Policy. 12:(4):1991;450-463
39. Tauxe R.V., Blake P.A. Epidemic cholera in Latin America. JAMA. 267:(10):1992;1388-1390
40. Factor S.H. Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis. 9:(8):2003;970-977
41. Nicolas P., Raphenon G., Guibourdenche M., Decousset L., Stor R., Gaye A.B. The 1998 Senegal epidemic of meningitis was due to the clonal expansion of A:4:P1.9, clone III-1, sequence type 5 Neisseria meningitidis strains. J Clin Microbiol. 38:(1):2000;198-200
42. Gagneux S., Hodgson A., Ehrhard I., Morelli G., Genton B., Smith T., et al. Microheterogeneity of serogroup A (subgroup III) Neisseria meningitidis during an outbreak in northern Ghana. Trop Med Int Health. 5:(4):2000;280-287
43. Molesworth A.M., Cuevas L.E., Connor S.J., Morse A.P., Thomson M.C. Environmental risk and meningitis epidemics in Africa. Emerg Infect Dis. 9:(10):2003;1287-1293
44. Tyrrell G.J., Chui L., Johnson M., Chang N., Rennie R.P., Talbot J.A. Outbreak of Neisseria meningitidis, Edmonton, Alberta, Canada. Emerg Infect Dis. 8:(5):2002;519-521
45. Patrick D.M., Champagne S., Goh S.H., Arsenault G., Thomas E., Shaw C., et al. Neisseria meningitidis carriage during an outbreak of serogroup C disease. Clin Infect Dis. 37:(9):2003;1183-1188
46. De Schrijver K., Maes I. An outbreak of serogroup C meningococcal disease in the province of Antwerp (Belgium) in 2001-2002. Eur J Epidemiol. 18:(11):2003;1073-1077
47. Navin T.R., McNabb S.J., Crawford J.T. The continued threat of tuberculosis. Emerg Infect Dis. 8:(11):2002;1187
48. Mukherjee J.S., Rich M.L., Socci A.R., Joseph J.K., Viru F.A., Shin S.S., et al. Programmes and principles in treatment of multidrug-resistant tuberculosis. Lancet. 363:(9407):2004;474-481
49. Webster R.G. Influenza: an emerging disease. Emerg Infect Dis. 4:(3):1998;436-441
50. Snacken R., Kendal A.P., Haaheim L.R., Wood J.M. The next influenza pandemic: lessons from Hong Kong, 1997. Emerg Infect Dis. 5:(2):1999;195-203
51. Brown H. WHO confirms human-to-human avian flu transmission. Lancet. 363:(9407):2004;462
52. Church D.L., Davies H.D., Mitton C., Semeniuk H., Logue M., Maxwell C., et al. Clinical and economic evaluation of rapid influenza A virus testing in nursing homes in Calgary, Canada. Clin Infect Dis. 34:(6):2002;790-795
53. Crosby A. America's forgotten pandemic: the influenza of 1918. 1989;Cambridge University Press, Cambridge (U.K.)
54. Dewan P.K., Fry A.M., Laserson K., Tierney B.C., Quinn C.P., Hayslett J.A., et al. Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001. Emerg Infect Dis. 8:(10):2002;1066-1072
55. Tan C.G., Sandhu H.S., Crawford D.C., Redd S.C., Beach M.J., Buehler J.W., et al. Surveillance for anthrax cases associated with contaminated letters, New Jersey, Delaware, and Pennsylvania, 2001. Emerg Infect Dis. 8:(10):2002;1073-1077
56. Hsu V.P., Lukacs S.L., Handzel T., Hayslett J., Harper S., Hales T., et al. Opening a bacillus anthracis-containing envelope, Capitol Hill, Washington, D.C.: the public health response. Emerg Infect Dis. 8:(10):2002;1039-1043
57. Tuljapurkar S., Li N., Boe C. A universal pattern of mortality decline in the G7 countries. Nature. 405:(6788):2000;789-792
58. United States Department of Commerce. 1990 census of population: general population characteristics. 1990;US Government Printing Office, Washington, DC
59. Donskey C.J., Ray A.J., Hoyen C.K., Fuldauer P.D., Aron D.C., Salvator A., et al. Colonization and infection with multiple nosocomial pathogens among patients colonized with vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol. 24:(4):2003;242-245
60. Yoshikawa T.T. Antimicrobial resistance and aging: beginning of the end of the antibiotic era? J Am Geriatr Soc. 50:(Suppl 7):2002;S226-S229
61. Kotilainen P., Routamaa M., Peltonen R., Evesti P., Eerola E., Salmenlinna S., et al. Eradication of methicillin-resistant Staphylococcus aureus from a health center ward and associated nursing home. Arch Intern Med. 161:(6):2001;859-863
62. Gushulak B.D., MacPherson D.W. Population mobility and infectious diseases: the diminishing impact of classical infectious diseases and new approaches for the 21st century. Clin Infect Dis. 31:(3):2000;776-780
63. Martens P., Hall L. Malaria on the move: human population movement and malaria transmission. Emerg Infect Dis. 6:(2):2000;103-109
64. United Nations. World urbanisation prospects: the 1996 revision. 1997;United Nations, NY
65. Toole M.J., Waldman R.J. The publilc health aspects of complex emergencies and refugee situations. Annu Rev Public Health. 18:1997;283-312
66. Misch A. Sanitation in the time of cholera. World Watch. 4:(4):1991;37-38
67. Guthmann J.P. Epidemic cholera in Latin America: spread and routes of transmission. J Trop Med Hyg. 98:(6):1995;419-427
68. Blake P.A. Epidemiology of cholera in the Americas. Gastroenterol Clin North Am. 22:(3):1993;639-660
69. Geddes A. Infection in the twenty-first century: predictions and postulates. J Antimicrob Chemother. 46:(6):2000;873-877
70. Lashley F.R. Factors contributing to the occurrence of emerging infectious diseases. Biol Res Nurs. 4:(4):2003;258-267
71. Stauffer W.M., Kamat D., Walker P.F. Screening of international immigrants, refugees, and adoptees. Prim Care. 29:(4):2002;879-905
72. Talisuna A.O., Bloland P., d'Alessandro U. History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev. 17:(1):2004;235-254
73. McGreevy P.B., Dietze R., Prata A., Hembree S.C. Effects of immigration on the prevalence of malaria in rural areas of the Amazon basin of Brazil. Instituto Oswaldo Cruz. 84:1989;485-491
74. Aramburu G.J., Ramal A.C., Witzig R. Malaria reemergence in the Peruvian Amazon region. Emerg Infect Dis. 5:(2):1999;209-215
75. Bradley D., Warhurst D., Blaze M., Smith V. Malaria imported into the United Kingdom in 1992 and 1993. Communicable Disease Report. 4:1994;R169-R171
76. Zucker J.R. Changing patterns of autochthonous malaria transmission in the United States: a review of recent outbreaks. Emerg Infect Dis. 2:(1):1996;37-43
77. Giacomini T., Mouchet J., Mathieu P., Petithory J.C. Study of 6 cases of malaria acquired near Roissy-Charles-de-Gaulle in 1994. Bull Acad Natl Med. 179:1995;335-351
78. Martens P. Malaria and global warming in perspective? Emerg Infect Dis. 6:(3):2000;313-314
79. Bigler M.O. Adolescent sexual behavior in the eighties. SIECUS Rep. 18:(1):1989;6-9
80. Feldmann J., Middleman A.B. Adolescent sexuality and sexual behavior. Curr Opin Obstet Gynecol. 14:(5):2002;489-493
81. Merrick J., Galil A. Trends in adolescent sexual risk behaviors. Int J Adolesc Med Health. 15:(1):2003;93-95
82. Pozniak A. What happened to sexually transmitted disease prevention? Curr Opin Infect Dis. 16:(1):2003;33-35
83. Cook P.A., Clark P., Bellis M.A., Ashton J.R., Syed Q., Hoskins A., et al. Re-emerging syphilis in the UK: a behavioural analysis of infected individuals. Commun Dis Public Health. 4:(4):2001;253-258
84. Kim A.A., Kent C.K., Klausner J.D. Risk factors for rectal gonococcal infection amidst resurgence in HIV transmission. Sex Transm Dis. 30:(11):2003;813-817
85. Beyrer C. Shan women and girls and the sex industry in Southeast Asia; political causes and human rights implications. Soc Sci Med. 53:(4):2001;543-550
86. Kilmarx P.H., Palanuvej T., Limpakarnjanarat K., Chitvarakorn A., St Louis M.E., Mastro T.D. Seroprevalence of HIV among female sex workers in Bangkok: evidence of ongoing infection risk after the "100% condom program" was implemented. J Acquir Immune Defic Syndr. 21:(4):1999;313-316
87. Tyndall M.W., Patrick D., Spittal P., Li K., O'Shaughnessy M.V., Schechter M.T. Risky sexual behaviours among injection drugs users with high HIV prevalence: implications for STD control. Sex Transm Infect. 78:(Suppl 1):2002;i170-i175
88. Aronson S., Osterholm M.T. Infectious diseases in child daycare: management and prevention, summary of the symposium and recommendations. Rev Infect Dis. 8:1986;672-679
89. Collet J.P., Ducruet T., Floret D., Cogan-Collet J., Honneger D., Boissel J.P. Daycare attendance and risk of first infectious disease. Eur J Pediatr. 150:(3):1991;214-216
90. Ferguson J.K., Jorm L.R., Allen C.D., Whitehead P.K., Gilbert G.L. Prospective study of diarrhoeal outbreaks in child long-daycare centres in western Sydney. Med J Aust. 163:(3):1995;137-140
91. Gomez-Barreto D., Calderon-Jaimes E., Rodriguez R.S., Espinosa L.E., Vina-Flores L., Jimenez-Rojas V. Carriage of antibiotic-resistant pneumococci in a cohort of a daycare center. Salud Publica Mex. 44:(1):2002;26-32
92. Geier M.R., Geier D.A. Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication. Exp Biol Med (Maywood). 228:(6):2003;660-664
93. Frenkel L.D., Nielsen K. Immunization issues for the 21st century. Ann Allergy Asthma Immunol. 90:(6 Suppl.3):2003;45-52
94. Geier D.A., Geier M.R. A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism. Med Sci Monit. 10:(3):2004;I33-I39
95. Baker J.P. The pertussis vaccine controversy in Great Britain, 1974-1986. Vaccine. 21:(25-6):2003;4003-4010
96. Vitek C.R., Wharton M. Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis. 4:(4):1998;539-550
97. Wallace D.J., Van Gilder T., Shallow S., Fiorentino T., Segler S.D., Smith K.E., et al. Incidence of food-borne illnesses reported by the food-borne diseases active surveillance network (FoodNet) - 1997. FoodNet Working Group. J Food Prot. 63:(6):2000;807-809
98. Kapperud G., Rorvik L.M., Hasseltvedt V., Hoiby E.A., Iversen B.G., Staveland K., et al. Outbreak of Shigella sonnei infection traced to imported iceberg lettuce. J Clin Microbiol. 33:(3):1995;609-614
99. de Wit M.A., Koopmans M.P., van Duynhoven Y.T. Risk factors for norovirus, Sapporo-like virus, and group A rotavirus gastroenteritis. Emerg Infect Dis. 9:(12):2003;1563-1570
100. Bell B.P., Goldoft M., Griffin P.M., Davis M.A., Gordon D.C., Tarr P.I., et al. A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA. 272:(17):1994;1349-1353
101. Hrudey S.E., Payment P., Huck P.M., Gillham R.W., Hrudey E.J. A fatal waterborne disease epidemic in Walkerton, Ontario: comparison with other waterborne outbreaks in the developed world. Water Sci Technol. 47:(3):2003;7-14
102. Holme R. Drinking water contamination in Walkerton, Ontario: positive resolutions from a tragic event. Water Sci Technol. 47:(3):2003;1-6
103. MacKenzie W.R., Schell W.L., Blair K.A., Addiss D.G., Peterson D.E., Hoxie N.J., et al. Massive outbreak of waterborne cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission. Clin Infect Dis. 21:(1):1995;57-62
104. Helms M., Vastrup P., Gerner-Smidt P., Molbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg Infect Dis. 8:(5):2002;490-495
105. Mahon B.E., Mintz E.D., Greene K.D., Wells J.G., Tauxe R.V. Reported cholera in the United States, 1992-1994: a reflection of global changes in cholera epidemiology. JAMA. 276:(4):1996;307-312
106. Cheneau Y., Roeder P.L., Obi T.U., Rweyemamu M.M., Benkirane A., Wojciechowski K.J. Disease prevention and preparedness: the Food and Agriculture Organization Emergency Prevention System. Rev Sci Tech. 18:(1):1999;122-134
107. McCarthy S.A., Khambaty F.M. International dissemination of epidemic Vibrio cholerae by cargo ship ballast and other nonpotable waters. Appl Environ Microbiol. 60:(7):1994;2597-2601
108. Ruiz G.M., Rawlings T.K., Dobbs F.C., Drake L.A., Mullady T., Huq A., et al. Global spread of microorganisms by ships. Nature. 408:(6808):2000;49-50
109. McCarthy S.A., McPhearson R.M., Guarino A.M., Gaines J.L. Toxigenic Vibrio cholerae O1 and cargo ships entering Gulf of Mexico. Lancet. 339:(8793):1992;624-625
110. Patz J.A., Epstein P.R., Burke T.A., Balbus J.M. Global climate change and emerging infectious diseases. JAMA. 275:(3):1996;217-223
111. Pachauri R. Intergovernmental Panel on Climate Change (IPCC): keynote address. UN World Summit on Sustainable Development in Johannesburg, South Africa. 26 August-4 September 2002. Environ Sci Pollut Res Int. 9:(6):2002;436-438
112. Mourino-Perez R.R. Oceanography and the seventh cholera pandemic. Epidemiology. 9:(3):1998;355-357
113. Nchinda T.C. Malaria: a reemerging disease in Africa. Emerg Infect Dis. 4:(3):1998;398-403
114. Coetzee M. Distribution of the African malaria vectors of the Anopheles gambiae complex. Am J Trop Med Hyg. 70:(2):2004;103-104
115. Martens P., Kovats R.S., Nijhof S., De Vries P., Livermore M.T.J., Bradley D.J., et al. Climate change and future populations at risk of malaria. Glob Environ Change. S9:1999;89-107
116. Fontenille D., Traore-Lamizana M., Diallo M., Thonnon J., Digoutte J.P., Zeller H.G. New vectors of Rift Valley fever in West Africa. Emerg Infect Dis. 4:(2):1998;289-293
117. Woods C.W., Karpati A.M., Grein T., McCarthy N., Gaturuku P., Muchiri E., et al. An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98. Emerg Infect Dis. 8:(2):2002;138-144
118. Gubler D. Epidemic dengue and dengue hemorrhagic fever: a global public health problem in the 21st century. Scheld W., Armstrong D., Hughes J.M. Emerging infections 1. 1998;1-14 ASM Press, Washington, DC
119. Centers for Disease Control and Prevention. Preventing emerging infectious diseases: a strategy for the 21st century. Overview of the updated CDC plan. MMWR Recomm Rep. 47:(RR-15):1998;1-14
120. Smith R.J. Diabetes mellitus: a 2003 perspective. Med Health R I. 86:(4):2003;92-95
121. Sarbah S.A., Younossi Z.M., Hepatitis C. an update on the silent epidemic. J Clin Gastroenterol. 30:(2):2000;125-143
122. Davis G.L. Chronic hepatitis C and liver transplantation. Rev Gastroenterol Disord. 4:(1):2004;7-17
123. Roderick P., Davies R., Raftery J., Crabbe D., Pearce R., Patel P., et al. Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation. J Med Screen. 10:(3):2003;148-156
124. Crawford J., Dale D.C., Lyman G.H. Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer. 100:(2):2004;228-237
125. Zimmer C. Microbiology. Do chronic diseases have an infectious root? Science. 293:(5537):2001;1974-1977
126. Sullivan J.L., Weinberg E.D. Iron and the role of Chlamydia pneumoniae in heart disease. Emerg Infect Dis. 5:(5):1999;724-726
127. Tang Y.W., Procop G.W., Persing D.H. Molecular diagnostics of infectious diseases. Clin Chem. 43:(11):1997;2021-2038
128. Pillai S.D. Rapid molecular detection of microbial pathogens: breakthroughs and challenges. Arch Virol Suppl. 13:1997;67-82
129. Wolk D., Mitchell S., Patel R. Principles of molecular microbiology testing methods. Infect Dis Clin North Am. 15:(4):2001;1157-1204
130. Boivin G., Cote S., Dery P., De Serres G., Bergeron M.G. Multiplex real-time PCR assay for detection of influenza and human respiratory syncytial viruses. J Clin Microbiol. 42:(1):2004;45-51
131. Bryant P.A., Venter D., Robins-Browne R., Curtis N. Chips with everything: DNA microarrays in infectious diseases. Lancet Infect Dis. 4:(2):2004;100-111
132. Patel J.B. 16S rRNA gene sequencing for bacterial pathogen identification in the clinical laboratory. Mol Diagn. 6:(4):2001;313-321
133. Relman D. Sequence-based methods for pathogen discovery: the complex assocations of microbes, microbial sequences, and host. Scheld W., Craig W.A., Hughes J.M. Emerging infections 4. 2000;69-81 ASM Press, Washington, DC
134. Choo Q., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A non-B hepatitis genome. Science. 244:1989;359-362
135. Dutly F., Altwegg M. Whipple's disease and "Tropheryma whippelii." Clin Microbiol Rev. 14:(3):2001;561-583
136. Normile D. Infectious diseases. WHO ramps up bird flu vaccine efforts. Science. 303:(5658):2004;609
137. Abbott A., Pearson H. Fear of human pandemic grows as bird flu sweeps through Asia. Nature. 427:(6974):2004;472-473
138. Davis S.R. The state of antibiotic resistance surveillance: an overview of existing activities and new strategies. Mil Med. 165:(7 Suppl 2):2000;35-39
139. Williams R.J., Heymann D.L. Containment of antibiotic resistance. Science. 279:(5354):1998;1153-1154
140. Ferber D. Antibiotic resistance. WHO advises kicking the livestock antibiotic habit. Science. 301:(5636):2003;1027
141. Wegener H.C., Aarestrup F.M., Jensen L.B., Hammerum A.M., Bager F. Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe. Emerg Infect Dis. 5:(3):1999;329-335
142. Okeke I.N., Lamikanra A., Edelman R. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerg Infect Dis. 5:(1):1999;18-27
143. Kellner J.D. Drug-resistant Streptococcus pneumoniae infections: clinical importance, drug treatment, and prevention. Semin Respir Infect. 16:(3):2001;186-195
144. Harbarth S., Albrich W., Brun-Buisson C. Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. Emerg Infect Dis. 8:(12):2002;1460-1467
145. Fridkin S.K., Hill H.A., Volkova N.V., Edwards J.R., Lawton R.M., Gaynes R.P., et al. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals. Emerg Infect Dis. 8:(7):2002;697-701
146. Albertini M.T., Benoit C., Berardi L., Berrouane Y., Boisivon A., Cahen P., et al. Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLS) in Northern France: a five-year multicentre incidence study. J Hosp Infect. 52:(2):2002;107-113
147. Rice L.B. Emergence of vancomycin-resistant enterococci. Emerg Infect Dis. 7:(2):2001;183-187
148. Williams R.J., Heymann D.L. Containment of antibiotic resistance. Science. 279:(5354):1998;1153-1154
149. Safdar N., Maki D.G. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med. 136:(11):2002;834-844
150. Snydman D.R. Shifting patterns in the epidemiology of nosocomial Candida infections. Chest. 123:(Suppl 5):2003;500S-503S
151. White T.C., Holleman S., Dy F., Mirels L.F., Stevens D.A. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother. 46:(6):2002;1704-1713
152. Munsiff S.S., Bassoff T., Nivin B., Li J., Sharma A., Bifani P., et al. Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997. Emerg Infect Dis. 8:(11):2002;1230-1238
153. Wegner S.A., Wallace M.R., Aronson N.E., Tasker S.A., Blazes D.L., Tamminga C., et al. Long-term efficacy of routine access to antiretroviral- resistance testing in HIV type 1-infected patients: results of the clinical efficacy of resistance testing trial. Clin Infect Dis. 38:(5):2004;723-730
154. Howard-Ruben J. The West Nile virus: an emerging public health challenge. ONS News. 18:(11):2003;3. 13
155. von Overbeck J. Insurance and epidemics: SARS, West Nile virus and Nipah virus. J Insur Med. 35:(3-4):2003;165-173
156. Lichtveld M.Y., Cioffi J.P. Public health workforce development: progress, challenges, and opportunities. J Public Health Manag Pract. 9:(6):2003;443-450
157. Strengthening the public health system for a healthier future. Issue brief (Grantmakers Health) 2003;17:1-41.
158. Morey S., Madden L. Building the infrastructure for public health. N S W Public Health Bull. 14:(3):2003;50-51
159. Kalipeni E., Oppong J. The refugee crisis in Africa and implications for health and disease: a political ecology approach. Soc Sci Med. 46:(12):1998;1637-1653
160. Ramlogan R. Environmental refugees: a review. Environ Conserv. 23:1996;81-88
161. Loeb M. SARS among critical care nurses, Toronto. Emerg Infect Dis. 10:(2):2004;251-255
162. Marmagas S.W., King L.R., Chuk M.G. Public health's response to a changed world: September 11, biological terrorism, and the development of an environmental health tracking network. Am J Public Health. 93:(8):2003;1226-1230
163. Ko K.S., Kim J.M., Kim J.W., Jung B.Y., Kim W., Kim I.J., et al. Identification of Bacillus anthracis by rpoB sequence analysis and multiplex PCR. J Clin Microbiol. 41:(7):2003;2908-2914
164. Traeger M.S., Wiersma S.T., Rosenstein N.E., Malecki J.M., Shepard C.W., Raghunathan P.L., et al. First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001. Emerg Infect Dis. 8:(10):2002;1029-1034